Please try another search
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 147.65 million compared to CNY 189.15 million a year ago. Net income was CNY 2.35 million compared to CNY 8.79 million a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 147.65 | 142.77 | 185.13 | 333.68 |
Gross Profit | 136.77 | 123.67 | 173.02 | 308.17 |
Operating Income | 4.43 | 0.245 | 22.34 | 55.86 |
Net Income | 2.35 | 18.74 | 21.45 | 59.65 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 2825.35 | 2876.69 | 2946.02 | 3031.01 |
Total Liabilities | 464.49 | 518.12 | 609.24 | 716.04 |
Total Equity | 2360.85 | 2358.56 | 2336.78 | 2314.98 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 43.94 | 69.3 | 110.47 | 51.51 |
Cash From Investing Activities | -3.81 | -9.89 | -26.78 | 227.03 |
Cash From Financing Activities | -2.67 | -105.81 | -72.33 | 64.41 |
Net Change in Cash | 37.5 | -46.57 | 11.33 | 343.12 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review